Clinical trials
Recruiting Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitari Vall d'Hebron Research Institute | 3 |
| American Thrombosis and Hemostasis Network | 1 |
| Children's Hospital of Philadelphia | 1 |
| Cyprus Institute of Neurology and Genetics | 1 |
| Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 1 |
| Novo Nordisk A/S | 1 |
| Riphah International University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 16 |
| Anemia, Sickle Cell | 9 |
| Hemoglobinopathies | 7 |
| beta-Thalassemia | 6 |
| Anemia | 4 |
| Genetic Diseases, Inborn | 3 |
| Hematologic Diseases | 3 |
| Hemostatic Disorders | 2 |
| Iron Metabolism Disorders | 2 |
| alpha-Thalassemia | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.